Skip to main content

Taking ATMPs to Market

The Cell and Gene Therapy Catapult (CGT Catapult) is an independent not-for-profit innovation and technology organisation committed to the advancement of cell and gene therapies. 

Learn about the presentation on 'Taking Advanced Therapy Medicinal Products (ATMPs) to Market' produced by CGT Catapult. The presentation slides are available as a PDF to download or view online.

Within the slides you will find information on:

  • The regulatory framework in EU
  • Therapy classification and case studies 
  • Early development support by EMA (EU) and MHRA (UK)
  • Pathways for market access in Europe, USA, and Japan
CGT Catapult: Taking ATMPs to Market

CGT Catapult's presentation on 'Taking Advanced Therapy Medicinal Products (ATMPs) to Market'

Note: This resource was created pre-BREXIT. For post-BREXIT guidance in the UK context, please see this page.


Did you find the content on this page useful? If not, you can leave us a message so we can improve Send us your thoughts